In contrast to other retroviruses, Mason-Pfizer monkey virus (M-PMV) assembles immature capsids in the cytoplasm. We have compared the ability of minimal assembly-competent domains from M-PMV and human immunodeficiency virus type 1 (HIV-1) to assemble in vitro into virus-like particles in the presence and absence of nucleic acids. A fusion protein comprised of the capsid and nucleocapsid domains of Gag (CANC) and its N-terminally modified mutant (DeltaProCANC) were used to mimic the assembly of the viral core and immature particles, respectively. In contrast to HIV-1, where CANC assembled efficiently into cylindrical structures, the same domains of M-PMV were assembly incompetent. The addition of RNA or oligonucleotides did not complement this defect. In contrast, the M-PMV DeltaProCANC molecule was able to assemble into spherical particles, while that of HIV-1 formed both spheres and cylinders. For M-PMV, the addition of purified RNA increased the efficiency with which DeltaProCANC formed spherical particles both in terms of the overall amount and the numbers of completed spheres. The amount of RNA incorporated was determined, and for both rRNA and MS2-RNA, quantities similar to that of genomic RNA were encapsidated. Oligonucleotides also stimulated assembly; however, they were incorporated into DeltaProCANC spherical particles in trace amounts that could not serve as a stoichiometric structural component for assembly. Thus, oligonucleotides may, through a transient interaction, induce conformational changes that facilitate assembly, while longer RNAs appear to facilitate the complete assembly of spherical particles.

Department of Biochemistry and Microbiology Institute of Chemical Technology Technicka 3 166 28 Prague Czech Republic

000      

00000naa 2200000 a 4500

001      

bmc07522648

003      

CZ-PrNML

005      

20111210134504.0

008      

090506s2006 xxu e eng||

009      

AR

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Ulbrich, Pavel, $d 1974- $7 xx0136336

245    10

$a Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins / $c Ulbrich P, Haubova S, Nermut MV, Hunter E, Rumlova M, Ruml T.

314    __

$a Department of Biochemistry and Microbiology, Institute of Chemical Technology, Technicka 3, 166 28 Prague, Czech Republic

520    9_

$a In contrast to other retroviruses, Mason-Pfizer monkey virus (M-PMV) assembles immature capsids in the cytoplasm. We have compared the ability of minimal assembly-competent domains from M-PMV and human immunodeficiency virus type 1 (HIV-1) to assemble in vitro into virus-like particles in the presence and absence of nucleic acids. A fusion protein comprised of the capsid and nucleocapsid domains of Gag (CANC) and its N-terminally modified mutant (DeltaProCANC) were used to mimic the assembly of the viral core and immature particles, respectively. In contrast to HIV-1, where CANC assembled efficiently into cylindrical structures, the same domains of M-PMV were assembly incompetent. The addition of RNA or oligonucleotides did not complement this defect. In contrast, the M-PMV DeltaProCANC molecule was able to assemble into spherical particles, while that of HIV-1 formed both spheres and cylinders. For M-PMV, the addition of purified RNA increased the efficiency with which DeltaProCANC formed spherical particles both in terms of the overall amount and the numbers of completed spheres. The amount of RNA incorporated was determined, and for both rRNA and MS2-RNA, quantities similar to that of genomic RNA were encapsidated. Oligonucleotides also stimulated assembly; however, they were incorporated into DeltaProCANC spherical particles in trace amounts that could not serve as a stoichiometric structural component for assembly. Thus, oligonucleotides may, through a transient interaction, induce conformational changes that facilitate assembly, while longer RNAs appear to facilitate the complete assembly of spherical particles.

650    _2

$a zvířata $7 D000818

650    _2

$a kapsida $x metabolismus $x ultrastruktura $7 D002213

650    _2

$a bezbuněčný systém $7 D002474

650    _2

$a genové produkty gag $x genetika $x metabolismus $7 D015683

650    _2

$a genom virový $x fyziologie $7 D016679

650    _2

$a HIV-1 $x fyziologie $x izolace a purifikace $x ultrastruktura $7 D015497

650    _2

$a lidé $7 D006801

650    _2

$a Masonův-Pfizerův opičí virus $x fyziologie $x izolace a purifikace $7 D016093

650    _2

$a mutace $7 D009154

650    _2

$a oligonukleotidy $x genetika $x metabolismus $7 D009841

650    _2

$a konformace proteinů $7 D011487

650    _2

$a terciární struktura proteinů $x účinky léků $7 D017434

650    _2

$a RNA ribozomální $x genetika $x metabolismus $7 D012335

650    _2

$a RNA virová $x genetika $x metabolismus $x ultrastruktura $7 D012367

650    _2

$a sestavení viru $x fyziologie $7 D019065

650    _2

$a financování organizované $7 D005381

655    _2

$a srovnávací studie $7 D003160

700    1_

$a Suchanová, Šárka $7 xx0128950

700    1_

$a Nermut, Milan $7 jk01083206

700    1_

$a Hunter, Eric

700    1_

$a Rumlová, Michaela, $d 1968- $7 ola20040226003

700    1_

$a Ruml, Tomáš, $d 1954- $7 nlk20030128618

773    0_

$w MED00003048 $t Journal of virology $g Roč. 80, č. 14 (2006), s. 7089-7099 $x 0022-538X

910    __

$a ABA008 $b x $y 9

990    __

$a 20090310084605 $b ABA008

991    __

$a 20111031102726 $b ABA008

999    __

$a ok $b bmc $g 650740 $s 503903

BAS    __

$a 3

BMC    __

$a 2006 $b 80 $c 14 $d 7089-7099 $i 0022-538X $m Journal of virology $x MED00003048

LZP    __

$a 2009-B3/ipme